Skip to main content
OpenTrials
Completed

NCT Number: NCT03196024

Corazon de la Familia (Heart of the Family)

The Corazón de la Familia study is a randomized controlled trial to examine the effects of a novel family-focused lifestyle modification intervention to reduce risk for type 2 diabetes and cardiovascular disease (CVD) among Hispanics/Latinos. Facilitated by community health workers, the family-focused intervention engages two members of a family in an educational program addressing lifestyle behaviors to support sustained engagement in healthy lifestyles among Hispanics with high risk for type 2 diabetes or CVD. In this study, we will conduct a randomized controlled trial using a 2-group design and compare the short-term and long-term impact of the family-focused active intervention to an individual-focused control condition on biological and behavioral type 2 diabetes and CVD risk factors. Furthermore, we will examine outcomes of participants in the family-focused intervention to determine how each family member's engagement in healthy lifestyle behaviors and level of support for the other family member's engagement in healthy lifestyle behaviors affects their own and their partner's outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Kentucky

Lexington, Kentucky, 40536-0232, United States

About this study

The Corazón de la Familia study is a randomized controlled trial conducted to examine if a novel family-focused lifestyle modification intervention is more effective in reducing risk for type 2 diabetes and cardiovascular disease (CVD) than an individual-focused lifestyle modification intervention. We will enroll 220 Hispanic family pairs or dyads, of whom one member has two or more risk factors for type 2 diabetes or CVD but does not have type 2 diabetes or CVD. The second member of the family dyad may or may not have type 2 diabetes or CVD or may or may not be at risk for type 2 diabetes or CVD. Of the 220 family dyads, 110 will be randomly selected to participate in the family-focused intervention and 110 will be randomly selected to participate in the individual-focused intervention. The interventions for both groups will be provided by community health workers. Both groups will receive eight educational sessions about healthy lifestyle behaviors and support to address personal and environmental barriers to engaging in healthy behaviors. After the eight sessions, the community health workers will follow up with participants once a month by phone over the next 12 months. Primary outcomes include short-term and long-term impact of the family-focused active intervention compared to the individual-focused control condition on type 2 diabetes and CVD biological risk factors (for example, blood pressure and weight) and behavioral risk factors (for example, physical activity and tobacco use). Outcomes are measured at baseline, immediately post-intervention, and at the end of the 12 month period of the study for both groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

We are enrolling family dyads, or 2 family members, one of whom is at-risk for type 2 diabetes or cardiovascular disease and the second of whom is a co-participating family member who may or may not be at risk for type 2 diabetes or cardiovascular disease.

Inclusion criteria

for the at-risk member of the dyad:

  • Is Hispanic or Latino
  • Is 18 years of age and older
  • Is a primary Spanish speaker
  • Has two or more risk factors for type 2 diabetes or cardiovascular disease including:
  • clinical diagnosis of hypertension;
  • clinical diagnosis of hyperlipidemia;
  • clinical diagnosis of prediabetes;
  • overweight or obese (body mass index ≥ 25 kg/m2);
  • is a current cigarette smoker;
  • male 45 years of age or older or female 55 years of age or older;
  • family history in first degree relative of type 2 diabetes or cardiovascular disease; or
  • is a female with a history of gestational diabetes mellitus or polycystic ovary syndrome.
  • Plan to be in Kentucky and Is willing to participate in the study for the next 12 months

Inclusion criteria

for the co-participating member of the dyad

  • Is 18 years of age and older
  • At a minimum, understands Spanish
  • Lives in the same household or in close proximity (no further than 25 miles distance) to the at-risk member of the dyad

Exclusion criteria

Exclusion criteria

for family dyads:

  • Dyads will be excluded if one or both dyad members have any of the following:
  • Have cognitive impairment that preclude them from understanding the consent process, answering questionnaires, or participating in the intervention;
  • Have a major psychiatric (e.g., schizophrenia) condition;
  • Are pregnant or nursing or plan on becoming pregnant within the next year since dietary needs will be different.

Exclusion criteria

that apply only to the at-risk member of the dyad:

  • Have known coronary artery or cerebrovascular disease;
  • Have a diagnosis of type 1 or type 2 diabetes;
  • Have medical contraindications to participate in a lifestyle intervention that includes unsupervised physical activity and weight loss

Treatment and study plan

Family-focused intervention arm

Behavioral

Family pairs including an individual family member at-risk for type 2 diabetes or CVD and a co-participating family member will be enrolled in the study. After completing baseline data they will be randomly selected to participate in one of the two study arms. For the family-focused arm, the family pair will attend 8 2-hour weekly educational sessions about type 2 diabetes and CVD risk reducing lifestyle behaviors. The sessions will be presented by community health workers (CHWs) in Spanish to groups of 5 to 6 family pairs. Following completion of the sessions, data will be collected from the family pairs. CHWs will call monthly to provide information and support through the end of the 12-month period at which time data will be collected from the family pairs.

Individual-focused intervention arm

Behavioral

Family pairs including an individual family member at-risk for type 2 diabetes or CVD and co-participating family member will be enrolled in the study. After completing baseline data pairs will be randomly selected to participate in one of two interventions. For the individual-focused intervention, the at-risk individual will attend 8 weekly 2-hour education sessions on type 2 diabetes and CVD risk reducing lifestyle behaviors. Sessions will be presented by CHWs in Spanish to groups of 10 to 12 individuals. Following completion of sessions, data will be collected from the individuals. CHWs will call monthly to provide information and support through the end of the 12-month period at which time data will be collected from the at-risk individuals and their co-participating family members.

Primary outcomes

  1. Change in body mass index (BMI)

    Time frame: Baseline, 3 months, and 12 months

    BMI based on measurements of weight and height and calculated as kg/m2

  2. Change in blood pressure

    Time frame: Baseline, 3 months, and 12 months

    Blood pressure assessed using calibrated sphygmomanometry

  3. Change in lipid profile

    Time frame: Baseline, 3 months, and 12 months

    Lipid profile includes LDL-cholesterol, HDL-cholesterol and triglycerides measured using point-of-care testing obtained by fingerstick.

  4. Change in hemoglobin A1c (HbA1c)

    Time frame: Baseline, 3 months, and 12 months

    HbA1c measured using point-of-care testing obtained by fingerstick.

  5. Change in level of physical activity

    Time frame: Baseline, 3 months, and 12 months

    Physical activity will be measured using the International Physical Activity Questionnaire (IPAQ) to assess the number of days in the last 7 days that the participant engaged in vigorous or moderate physical activity and confirmed by comparing responses to number of daily steps over 7 days assessed with a Fitbit

  6. Change in diet quality

    Time frame: Baseline, 3 months, and 12 months

    Diet quality will be measured using the Food Frequency Questionnaire

  7. Change in tobacco use

    Time frame: Baseline, 3 months, and 12 months

    Urine cotinine levels will be used to assess tobacco use

Secondary outcomes

  1. Support for healthy behaviors

    Time frame: Baseline, 3 months, and 12 months

    Self report of experience of social support for healthy behaviors

Sponsors and collaborators

Lead sponsor

Gia Mudd

Other

Collaborators

  • National Institute of Nursing Research (NINR)
  • National Institutes of Health (NIH)

Registry information

Official study title

A Randomized Controlled Trial to Examine a Healthy Lifestyle Intervention With Families to Prevent Cardiovascular Disease and Type 2 Diabetes in Hispanics/Latinos

Important dates

Study start
2017
Primary completion
2023
Study completion
2023
First posted
Jun 22, 2017
Registry last updated
Mar 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.